Home Pharma China Web Edition Pharma China Archives Online Databases Subscription/Order/Info Event Calendar China Pharma Providers About Us
Location: Home > Pharma China Web Edition > API/Bulk Drug News    
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Expert Opinions
Case Studies
Company Profiles
Editor´s Picks
WiCON International Group
311 Sayre Drive,
Princeton, NJ 08540, USA
Tel/Fax: +1 702-9953905

China Head Office
c/o Beijing Jicai PharmTech
Suite B-17D, Oriental Kenzo Plaza
48 Dongzhimenwai Dajie
Dongcheng District
Beijing 100027, China
Tel: +86 10 84476010
Fax: +86 10 84476010
API/Bulk Drug News
Athenex Voluntarily Suspends Production at Its Chongqing API Plan... 6/13/2019
China Issues Draft Positive List of Antibacterial Active Ingredie... 5/10/2019
Chinese API Industry's Environmental Shake-up Disrupts Vitamin C ... 4/30/2019
U.S. Senators Propose Bill to Sanction Chinese Pharmchem Cos over... 4/18/2019
Lonza's Specialty API Business Disrupted by Chinese Plant Explosi... 4/18/2019
Huahai Pharma Involved In Another Blood Pressure Drug Recall 1/21/2019
Novo Nordisk Pharmatech A/S signs Asia Pacific distribution agree... 1/16/2019
Trade Bodies Warns API Supply Chain Disruptions from Chinese Plan... 1/9/2019
India Seeks to Reduce Reliance on Chinese Pharma Imports 1/9/2019
USFDA Warns Zhejiang Huahai for Failure to Detect Valsartan API I... 12/11/2018
Chinese Heparin Maker Yibin Lihao Bio Banned by EMA over Contamin... 11/30/2018
Huahai Pharma Faces Lawsuits on Cancer-Causing Valsartan in the U... 10/23/2018
Zheijiang Huahai Placed under Increased Supervision 10/15/2018
EU, U.S. and Canada Investigating Second Impurity in Huahai's Val... 9/14/2018
EU Regulators Issue Notice on a Chinese Anticancer API After Reje... 9/13/2018
USFDA Recalls Thyroid Drugs Containing Chinese API over GMP and Q... 8/22/2018
Indian Drugmakers Hit by Rising Prices of Chinese Intermediates 8/16/2018
FDA Warns Four Manufacturers from China, India and Canada 8/14/2018
WuXi STA's Jinshan API Plant Passes 4th U.S. FDA Inspection (free) 7/25/2018
Medicines Containing Huahai's Valsartan API Recalled in EU and U.... 7/17/2018
EMA Reviewing and Recalling Medicines Containing Valsartan from Z... 7/6/2018
U.S. FDA Warns Another Chinese API Maker for GMP Flaws 7/6/2018
Bain Reportedly Near Deal to Acquire DSM Sinochem Pharma 6/28/2018
U.S. FDA Warns Henan Lihua Pharma over Data Integrity Issues 6/28/2018
Page:1/1    Total number of articles:24  :[1]

© Wicon International Group  Support by: www.heightow.com   Site map | Contact Us | Links